Age over sibling: Younger unrelated donors provide superior outcomes compared to sibling donors in fully matched HCT in older AML/MDS patients.
Elderly adults represent a substantial proportion of patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS); however, preferential selection of matched related donors (MRD) for elderly allogeneic hematopoietic cell (HCT) recipients is challenged by the excellent outcomes of HCT from unrelated ma...